Suppr超能文献

2020 - 2023年维多利亚市新冠病毒病疫苗接种状况及与该病死亡相关的因素:横断面研究

COVID-19 vaccination status and factors associated with deaths from the disease, Vitória, 2020-2023: cross-sectional study.

作者信息

Comerio Tatiane, Cola João Paulo, Mascarello Keila Cristina, Sales Carolina Maia Martins, Freire Brenda Silva, Vasconcelos Adjane da Silva, Souza Marcia Christina de, Maciel Ethel Leonor Noia

机构信息

Universidade Federal do Espírito Santo, Programa de Pós-Graduação em Saúde Coletiva, Vitória, ES, Brzsil.

Secretaria Municipal de Saúde, Vitória, ES, Brazil.

出版信息

Epidemiol Serv Saude. 2025 Aug 8;34:e20240700. doi: 10.1590/S2237-96222025v34e20240700.en. eCollection 2025.

Abstract

OBJECTIVE

To analyze the vaccination status against COVID-19 and factors associated with deaths from the disease.

METHOD

Cross-sectional study with secondary data on deaths from COVID-19 in the city of Vitória, Espírito Santo, between February 2020 and December 2023. Individuals under 18 years of age and those with unavailable vaccination status were excluded. Relative and absolute frequencies were calculated by vaccination status. Poisson regression was used to calculate crude and adjusted prevalence ratios (PR) and 95% confidence intervals (95% CI).

RESULTS

A total of 1,460 deaths were included, of which 244 (16.7%) had received ≥2 doses of the vaccines. Among the unvaccinated individuals, the highest frequency of deaths was recorded in individuals aged 60 to 79 years (47.9%), male (56.4%), and non-white race/skin color (53.0%). The PR of death in vaccinated individuals was higher in people ≥80 years old (PR 5.55; 95%CI 2.92; 10.55), 60-79 years old (PR 3.61; 95%CI 1.95; 6.69), with chronic lung disease (PR 1.35; 95%CI 1.03; 1.78) or chronic neurological disease (PR 1.37; 95%CI 1.08; 1.72), respiratory distress (PR 1.51; 95%CI 1.02; 2.23), desaturation (PR 1.97; 95%CI 1.35; 2.88) and adynamia (PR 2.80; 95%CI 2.02; 3.90). People with 1-4 years of schooling (PR 0.63; 95%CI 0.44; 0.90), 5-8 years of schooling (PR 0.57; 95%CI 0.39; 0.84), ≥8 years of schooling (PR 0.66; 95%CI 0.45; 0.97) had a lower prevalence.

CONCLUSION

The highest prevalence of deaths among vaccinated individuals was associated with age ≥60 years, chronic lung or neurological disease, respiratory distress, desaturation, and adynamia. Loss of immunological memory in the elderly indicates the need for vaccine boosters to prevent deaths.

摘要

目的

分析新冠病毒疫苗接种情况以及与该疾病死亡相关的因素。

方法

采用横断面研究,利用2020年2月至2023年12月间圣埃斯皮里图州维多利亚市新冠病毒死亡病例的二手数据。排除18岁以下个体以及疫苗接种情况不明者。按疫苗接种情况计算相对频率和绝对频率。采用泊松回归计算粗患病率比(PR)和调整患病率比以及95%置信区间(95%CI)。

结果

共纳入1460例死亡病例,其中244例(16.7%)接种了≥2剂疫苗。在未接种疫苗的个体中,60至79岁(47.9%)、男性(56.4%)和非白人种族/肤色(53.0%)的死亡频率最高。≥80岁(PR 5.55;95%CI 2.92;10.55)、60 - 79岁(PR 3.61;95%CI 1.95;6.69)、患有慢性肺病(PR 1.35;95%CI 1.03;1.78)或慢性神经疾病(PR 1.37;95%CI 1.08;1.72)、呼吸窘迫(PR 1.51;95%CI 1.02;2.23)、血氧饱和度降低(PR 1.97;95%CI 1.35;2.88)和肌无力(PR 2.80;95%CI 2.02;3.90)的接种疫苗个体的死亡PR较高。接受1 - 4年教育(PR 0.63;95%CI 0.44;0.90)、5 - 8年教育(PR 0.57;95%CI 0.39;0.84)、≥8年教育(PR 0.66;95%CI 0.45;0.97)的个体患病率较低。

结论

接种疫苗个体中死亡的最高患病率与年龄≥60岁、慢性肺病或神经疾病、呼吸窘迫、血氧饱和度降低和肌无力有关。老年人免疫记忆丧失表明需要加强疫苗接种以预防死亡。

相似文献

1
COVID-19 vaccination status and factors associated with deaths from the disease, Vitória, 2020-2023: cross-sectional study.
Epidemiol Serv Saude. 2025 Aug 8;34:e20240700. doi: 10.1590/S2237-96222025v34e20240700.en. eCollection 2025.
2
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
JAMA Netw Open. 2024 Jul 1;7(7):e2419258. doi: 10.1001/jamanetworkopen.2024.19258.
4
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
5
8
Neurological manifestations of acute SARS-CoV-2 infection in a reference hospital in Bahia, Brazil.
Braz J Infect Dis. 2025 May 26;29(4):104542. doi: 10.1016/j.bjid.2025.104542.
9
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 Years.
JAMA Netw Open. 2025 Feb 3;8(2):e2459672. doi: 10.1001/jamanetworkopen.2024.59672.

本文引用的文献

1
COVID-19 vaccines: Immune correlates and clinical outcomes.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2324549. doi: 10.1080/21645515.2024.2324549. Epub 2024 Mar 22.
3
The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths.
PLoS One. 2023 Apr 25;18(4):e0275699. doi: 10.1371/journal.pone.0275699. eCollection 2023.
4
Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.
Front Endocrinol (Lausanne). 2022 Jun 3;13:780872. doi: 10.3389/fendo.2022.780872. eCollection 2022.
5
Public health impact of covid-19 vaccines in the US: observational study.
BMJ. 2022 Apr 27;377:e069317. doi: 10.1136/bmj-2021-069317.
6
Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort.
Lancet Healthy Longev. 2022 Apr;3(4):e242-e252. doi: 10.1016/S2666-7568(22)00035-6. Epub 2022 Mar 21.
8
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
JAMA Intern Med. 2022 Feb 1;182(2):197-205. doi: 10.1001/jamainternmed.2021.7949.
9
A systematic review of racial/ethnic and socioeconomic disparities in COVID-19.
Int J Equity Health. 2021 Nov 24;20(1):248. doi: 10.1186/s12939-021-01582-4.
10
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
JAMA. 2021 Nov 23;326(20):2043-2054. doi: 10.1001/jama.2021.19499.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验